SSA
MIST icon

Schonfeld Strategic Advisors’s Milestone Pharmaceuticals MIST Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-146,806
Closed -$578K – 2361
2023
Q1 		$578K Buy
146,806
+65,821
+81% +$241K 0.01% 1125
2022
Q4 		$321K Buy
+80,985
New +$426K ﹤0.01% 1758
2020
Q3 		– Sell
-33,200
Closed -$125K – 1537
2020
Q2 		$125K Buy
+33,200
New +$107K ﹤0.01% 1159

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Schonfeld Strategic Advisors's MIST Position: Q2 2023 in Review

Schonfeld Strategic Advisors sold out of Milestone Pharmaceuticals (MIST) in Q2 2023, closing a stake of 146,806 shares — an estimated $578K sold.

Schonfeld Strategic Advisors first reported a position in MIST in Q2 2020 and held it in 3 quarters. The position peaked at $578K in Q1 2023. 48 funds tracked by Wall St. Rank hold MIST as of Q2 2023.

  • Schonfeld Strategic Advisors reported no remaining Milestone Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 146,806 Milestone Pharmaceuticals shares in Q2 2023, an estimated $578K.
  • Schonfeld Strategic Advisors first reported a position in Milestone Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's Milestone Pharmaceuticals position peaked at $578K in Q1 2023.
  • 48 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.